- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Gemina Laboratories Ltd.: Gemina Announces Private Placement Offering | 219 | ACCESS Newswire | NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESS Newswire / July 13, 2026 / Gemina Laboratories Ltd. (the "Company" or "Gemina") is pleased... ► Artikel lesen | |
| 08.04. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 08.04.2026 | 920 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 08.04.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 08.04.2026ISIN NameCA09173B1076 BITFARMS... ► Artikel lesen | |
| 30.03. | XFRA 8I7: AUSSETZUNG/SUSPENSION | 200 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILGEMINA LABS LTD... ► Artikel lesen | |
| 25.03. | Gemina Laboratories Ltd: Gemina Laboratories to delist from CSE March 27 | 1 | Stockwatch | ||
| GEMINA LABORATORIES Aktie jetzt für 0€ handeln | |||||
| 25.03. | CSE Bulletin: Delist - Gemina Laboratories Ltd. (GLAB) | 140 | Newsfile | Le 25 mars/March 2026
Gemina Laboratories Ltd. ("Gemina") has announced it has obtained the approval of its disinterested shareholders at its annual general and special meeting held on March 13,... ► Artikel lesen | |
| 25.03. | Gemina Laboratories Ltd. Announces Delisting from the CSE | 431 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / March 25, 2026 / Gemina Laboratories Ltd. (CSE:GLAB) ("Gemina" or the "Company") announces that that the Canadian Securities Exchange (the "CSE") has approved is application... ► Artikel lesen | |
| 30.12.25 | Gemina Laboratories Ltd.: Debenture Offering and Delisting | 503 | ACCESS Newswire | NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESS Newswire / December 30, 2025 / Gemina Laboratories Ltd. (CSE:GLAB) (the "Company" or "Gemina")... ► Artikel lesen | |
| 01.10.25 | Gemina Laboratories Ltd.: Gemina Laboratories Announces Termination of Transaction | 388 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / October 1, 2025 / Gemina Laboratories Ltd. (CSE:GLAB) (the "Company" or "Gemina") announces that further to its news release dated November 13, 2024, the Company will... ► Artikel lesen |
8 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BRIGHTSPRING HEALTH SERVICES | 69,68 | +0,01 % | Raymond James initiates BrightSpring Health stock with outperform rating | ||
| BILLIONTOONE | 124,59 | -0,22 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 21,210 | +0,05 % | Kaplan Fox & Kilsheimer LLP: Kaplan Fox Alerts Investors of Alignment Healthcare, Inc. (ALHC) to an Investigation of Potential Securities Law Violations | New York, New York--(Newsfile Corp. - July 10, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. ("Alignment Healthcare" or... ► Artikel lesen | |
| BETA BIONICS | 16,860 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | IRVINE, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| GENEDX | 62,37 | -0,10 % | Piper Sandler raises GeneDx stock price target on coverage policy | ||
| HEARTFLOW | 25,500 | +0,04 % | Heartflow, Inc.: New Data at SCCT 2026 Reinforce Heartflow Plaque Analysis as the Standard for AI-Powered Coronary Artery Disease Management | ||
| ADAPTHEALTH | 10,190 | 0,00 % | AdaptHealth Flags Material Breach After Threat Actor Accessed Patient Management Systems | ||
| PROCEPT BIOROBOTICS | 19,300 | -0,05 % | PROCEPT BioRobotics to Report Second Quarter 2026 Financial Results on August 4th, 2026 | ||
| PROGYNY | 32,360 | 0,00 % | KeyBanc raises Progyny stock price target on utilization strength | ||
| LIFESTANCE HEALTH GROUP | 10,795 | +0,05 % | LifeStance Health Group, Inc.: LifeStance Reports First Quarter 2026 Results | SCOTTSDALE, Ariz., May 07, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 28,030 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports First Quarter 2026 Financial Results | Strong First Quarter Performance and Operating ExecutionReiterated Full-Year 2026 Guidance Reflects Continued Momentum ARLINGTON, Va., May 07, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq:... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 9,350 | +0,11 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Completes Acquisition of Family First Homecare and Updates Full Year 2026 Guidance | ATLANTA, June 02, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient... ► Artikel lesen | |
| ONCOLOGY INSTITUTE | 6,290 | +0,16 % | BTIG hebt Kursziel für Oncology Institute Aktie nach Umschuldung auf 9 US-Dollar an | ||
| CLEARPOINT NEURO | 15,960 | 0,00 % | EpilepsyGTx Taps ClearPoint Neuro for EPY201 Clinical Trial Delivery | ||
| PACS GROUP | 44,920 | 0,00 % | Hohes Handelsaufkommen bei Optionen der Pacs Group |
Das Unternehmen GEMINA LABORATORIES LTD kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,017 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GEMINA LABORATORIES LTD finden Sie auf Wallstreet Online.